Abbott closes $890m acquisition of Cardiovascular Systems
Abbott has closed the previously announced $890 million acquisition of Cardiovascular Systems, Inc. (CSI), which has developed an atherectomy system for the treatment of peripheral and coronary artery disease. As per the terms of the deal announced in February 2023, Cardiovascular Systems’ stockholders were offered $20 per share by Abbott. Cardiovascular Systems, which was trading […]